Publications by authors named "Sonya Vanpatten"

Claim this Profile
P
Protease-Resistant Azapeptide GLP-1 Analogue Improves Metabolic Control in Diet-Induced Obesity.
Mingzhu He, Kai Fan Cheng, Sonya VanPatten, Marcelo D T Torres, Bayan Al Jabari

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Drug Cocktail Therapy Improves Survival and Neurological Function after Asphyxial Cardiac Arrest in Rodents.
Rishabh C Choudhary, Muhammad Shoaib, Kei Hayashida, Tai Yin, Santiago J Miyara, Sonya Vanpatten

Cells· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidates.
Ahmad Altiti, Mingzhu He, Sonya VanPatten, Kai Fan Cheng, Umair Ahmed

Nat Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azapeptides -A History of Synthetic Milestones and Key Examples.
Kai Fan Cheng, Sonya VanPatten, Mingzhu He, Yousef Al-Abed

Curr Med Chem· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 and interferon blockade.
Betty Diamond, Bruce T Volpe, Sonya VanPatten, Yousef Al Abed

Mol Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics.
Sonya VanPatten, Mingzhu He, Ahmad Altiti, Kai F Cheng, Mustafa H Ghanem

Future Med Chem· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic insights into high mobility group box-1 (HMGb1)-induced Toll-like receptor 4 (TLR4) dimer formation.
Shan Sun, Mingzhu He, Sonya VanPatten, Yousef Al-Abed

J Biomol Struct Dyn· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rediscovering MIF: New Tricks for an Old Cytokine.
James Harris, Sonya VanPatten, Nadia S Deen, Yousef Al-Abed, Eric F Morand

Trends Immunol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target.
Sonya VanPatten, Yousef Al-Abed

J Med Chem· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A structural investigation of FISLE-412, a peptidomimetic compound derived from saquinavir that targets lupus autoantibodies.
Mingzhu He, Kai Fan Cheng, Sonya VanPatten, Ona Bloom, Betty Diamond

Bioorg Med Chem Lett· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The challenges of modulating the 'rest and digest' system: acetylcholine receptors as drug targets.
Sonya VanPatten, Yousef Al-Abed

Drug Discov Today· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of novel muscarinic M3 receptor ligand C1213 in pulmonary arterial hypertension models.
Mohamed Ahmed, Sonya VanPatten, Satyan Lakshminrusimha, Hardik Patel, Thomas R Coleman

Physiol Rep· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amending HIV Drugs: A Novel Small-Molecule Approach To Target Lupus Anti-DNA Antibodies.
Sonya VanPatten, Shan Sun, Mingzhu He, Kai Fan Cheng, Ahmad Altiti

J Med Chem· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell death.
Milica Vujicic, Ivana Nikolic, Tamara Krajnovic, Kai-Fan Cheng, Sonya VanPatten

Eur J Pharmacol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factor.
Mingzhu He, Christine Metz, Kai Fan Cheng, Jie Ling, Thomas Coleman, Sonya VanPatten

Arch Pharm (Weinheim)· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elaborate ligand-based modeling reveal new migration inhibitory factor inhibitors.
Mahmoud A Al-Sha'er, Sonya VanPatten, Yousef Al-Abed, Mutasem O Taha

J Mol Graph Model· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity.
Yousef Al-Abed, Christine N Metz, Kai Fan Cheng, Bayan Aljabari, Sonya VanPatten

Proc Natl Acad Sci U S A· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.
Yousef Al-Abed, Sonya VanPatten

Future Med Chem· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracerebroventricular leptin regulates hepatic cholesterol metabolism.
Sonya Vanpatten, George B Karkanias, Luciano Rossetti, David E Cohen

Biochem J· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis